(December 8, 2021, 1:32 PM EST) -- NEW YORK — Two drug companies controlled by Martin Shkreli on Dec. 7 agreed to pay $40 million to resolve civil antitrust allegations by the Federal Trade Commission and seven states that they blocked the development of generic versions of the drug Daraprim....